ArticleBlood2014

TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo.

Hayley Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.